Company Profile

The Genelux Difference

Genelux is a Phase 3 biopharmaceutical company developing powerful therapeutics for patients suffering from difficult-to-treat cancers. The Company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor’s sophisticated defense mechanisms.

Equiniti Trust Company, LLC (EQ)

6201 15th Ave 

Brooklyn, NY 11219 

Call Center is open Monday through Friday, 8 a.m. to 8 p.m. ET. 

(800) 937-5449 toll free 

(718) 921-8124 international